2/16
08:11 am
stok
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Medium
Report
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
2/16
05:28 am
stok
Rating for STOK
Low
Report
Rating for STOK
2/16
05:28 am
stok
Rating for STOK
Low
Report
Rating for STOK